Helen S. Pentikis

683 total citations
37 papers, 557 citations indexed

About

Helen S. Pentikis is a scholar working on Epidemiology, Pediatrics, Perinatology and Child Health and Microbiology. According to data from OpenAlex, Helen S. Pentikis has authored 37 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Microbiology. Recurrent topics in Helen S. Pentikis's work include Reproductive tract infections research (7 papers), Statistical Methods in Clinical Trials (6 papers) and Herpesvirus Infections and Treatments (5 papers). Helen S. Pentikis is often cited by papers focused on Reproductive tract infections research (7 papers), Statistical Methods in Clinical Trials (6 papers) and Herpesvirus Infections and Treatments (5 papers). Helen S. Pentikis collaborates with scholars based in United States, Norway and France. Helen S. Pentikis's co-authors include Simon Hatch, Thomas M. Ludden, Carol Braun Trapnell, William P. Forbes, Mario Ángel-González, John M. Strong, Heleen H. DeCory, Jerry M. Collins, Jagadeesh Aluri and Min Ren and has published in prestigious journals such as Journal of Clinical Oncology, Blood and CHEST Journal.

In The Last Decade

Helen S. Pentikis

35 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen S. Pentikis United States 14 109 99 89 87 76 37 557
Pinfang Huang China 14 73 0.7× 137 1.4× 24 0.3× 55 0.6× 43 0.6× 50 495
Jacqueline L. Olin United States 13 61 0.6× 92 0.9× 29 0.3× 117 1.3× 29 0.4× 36 468
Nicolas Bouvier France 15 242 2.2× 76 0.8× 62 0.7× 153 1.8× 22 0.3× 54 874
Jane K. McGavin New Zealand 10 115 1.1× 62 0.6× 62 0.7× 90 1.0× 17 0.2× 11 577
Micha Levi United States 15 113 1.0× 25 0.3× 52 0.6× 114 1.3× 26 0.3× 37 607
Robert S. Jones United States 10 70 0.6× 103 1.0× 18 0.2× 226 2.6× 42 0.6× 23 687
Stefaan Rossenu Belgium 19 96 0.9× 117 1.2× 201 2.3× 153 1.8× 22 0.3× 35 976
Amitabh Prakash New Zealand 11 55 0.5× 48 0.5× 21 0.2× 61 0.7× 44 0.6× 16 623
Jane Harness United States 12 55 0.5× 126 1.3× 231 2.6× 120 1.4× 52 0.7× 23 1.0k
Kun‐Pin Hsieh Taiwan 12 64 0.6× 53 0.5× 63 0.7× 78 0.9× 10 0.1× 22 430

Countries citing papers authored by Helen S. Pentikis

Since Specialization
Citations

This map shows the geographic impact of Helen S. Pentikis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen S. Pentikis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen S. Pentikis more than expected).

Fields of papers citing papers by Helen S. Pentikis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen S. Pentikis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen S. Pentikis. The network helps show where Helen S. Pentikis may publish in the future.

Co-authorship network of co-authors of Helen S. Pentikis

This figure shows the co-authorship network connecting the top 25 collaborators of Helen S. Pentikis. A scholar is included among the top collaborators of Helen S. Pentikis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen S. Pentikis. Helen S. Pentikis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pentikis, Helen S., et al.. (2020). An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis. Reproductive Sciences. 27(2). 523–528. 7 indexed citations
2.
Lin, Tara L., Laura F. Newell, Robert K. Stuart, et al.. (2019). A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias. Cancer Chemotherapy and Pharmacology. 84(1). 163–173. 13 indexed citations
3.
Mirza, Mansoor Raza, Lucy Gilbert, Michel Fabbro, et al.. (2017). The exposure-response relationship of niraparib in patients with gBRCAmut and non-gBRCAmut: Results from the ENGOT-OV16/NOVA Trial. Annals of Oncology. 28. v331–v332. 8 indexed citations
4.
Pentikis, Helen S., et al.. (2017). A review of the pharmacokinetic properties of SYM-1219, a single oral dose granule formulation containing 2 g of secnidazole, for the treatment of bacterial vaginosis. American Journal of Obstetrics and Gynecology. 217(6). 715–716. 2 indexed citations
5.
Darpö, Börje, et al.. (2017). Thorough QT/QTc Evaluation of the Cardiac Safety of Secnidazole at Therapeutic and Supratherapeutic Doses in Healthy Individuals. The Journal of Clinical Pharmacology. 58(3). 286–293. 5 indexed citations
6.
7.
8.
Luzina, Irina G., et al.. (2015). Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 355(1). 13–22. 14 indexed citations
9.
Yardley, Denise A., et al.. (2014). A phase 1 study to assess the food effect on the pharmacokinetics (PK) of entinostat.. Journal of Clinical Oncology. 32(15_suppl). 591–591.
10.
Shumaker, Robert, et al.. (2014). Influence of hepatic impairment on lenvatinib pharmacokinetics following single‐dose oral administration. The Journal of Clinical Pharmacology. 55(3). 317–327. 49 indexed citations
11.
Matson, Mark, et al.. (2009). A Study of the Safety and Pharmacokinetics of Multiple Ascending Doses of FV-100 in Healthy Subjects. Antiviral Research. 82(2). A49–A49. 2 indexed citations
12.
Zhou, Xiao‐Jian, et al.. (2009). Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment. The Journal of Clinical Pharmacology. 49(6). 725–734. 3 indexed citations
13.
Pentikis, Helen S., et al.. (2007). The Effect of Multiple‐Dose, Oral Rifaximin on the Pharmacokinetics of Intravenous and Oral Midazolam in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(10). 1361–1369. 32 indexed citations
14.
Trapnell, Carol Braun, et al.. (2005). Systemic pharmacokinetics of rifaximin (RFX) in subjects with shigellosis. Clinical Pharmacology & Therapeutics. 77(2). P60–P60. 2 indexed citations
15.
Dineen, Martin, et al.. (2005). An Evaluation of the Pharmacokinetics and Pharmacodynamics of the Histrelin Implant for the Palliative Treatment of Prostate Cancer. The Journal of Clinical Pharmacology. 45(11). 1245–1249. 16 indexed citations
16.
Pentikis, Helen S., et al.. (2002). Methylphenidate Bioavailability in Adults When an Extended-Release Multiparticulate Formulation Is Administered Sprinkled on Food or as an Intact Capsule. Journal of the American Academy of Child & Adolescent Psychiatry. 41(4). 443–449. 34 indexed citations
17.
Ángel-González, Mario, et al.. (2002). Methylphenidate bioavailability from two extended-release formulations. International Journal of Clinical Pharmacology and Therapeutics. 40(4). 175–184. 67 indexed citations
18.
Pentikis, Helen S., et al.. (1997). THE EFFECT OF FOOD ON THE BIOAVAILABILITY OF EBASTINE. American Journal of Therapeutics. 4(2). 80–84. 8 indexed citations
19.
Ludden, Thomas M., et al.. (1997). Effect of Albumin on the Estimation, In Vitro, of Phenytoin Vmax and Km Values: Implications for Clinical Correlation. Journal of Pharmacology and Experimental Therapeutics. 282(1). 391–396. 49 indexed citations
20.
Pentikis, Helen S., James D. Henderson, Nhan L. Tran, & Thomas M. Ludden. (1996). Bioequivalence: Individual and Population Compartmental Modeling Compared to the Noncompartmental Approach. Pharmaceutical Research. 13(7). 1116–1121. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pinfang Huang Breakdown of academic impact, for papers by Jacqueline L. Olin Breakdown of academic impact, for papers by Nicolas Bouvier Breakdown of academic impact, for papers by Jane K. McGavin Breakdown of academic impact, for papers by Micha Levi Breakdown of academic impact, for papers by Robert S. Jones Breakdown of academic impact, for papers by Stefaan Rossenu Breakdown of academic impact, for papers by Amitabh Prakash Breakdown of academic impact, for papers by Jane Harness Breakdown of academic impact, for papers by Kun‐Pin Hsieh
Rankless by CCL
2026